TTNP
- Titan Pharmaceuticals, Inc.
()
Overview
Company Summary
Titan Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing and commercializing therapeutics for various medical conditions. The company focuses primarily on the treatment of addiction and central nervous system disorders.
Titan Pharmaceuticals is widely known for its innovative drug delivery technologies, specifically its proprietary ProNeura technology. This technology allows for the long-term, continuous delivery of medications through small implantable devices. The company focuses on developing implantable devices for the treatment of chronic diseases, leveraging the benefits of controlled drug release.
The flagship product of Titan Pharmaceuticals is Probuphine, which utilizes ProNeura technology. Probuphine is an implantable formulation of buprenorphine, a medication used for the treatment of opioid addiction. The implanted device delivers a steady, nontoxic dose of the drug over six months, eliminating the need for daily medication or frequent clinic visits.
In addition to Probuphine, Titan Pharmaceuticals has also conducted research and development in other therapeutic areas. They have explored the potential of their ProNeura technology for the treatment of Parkinson's disease, hypothyroidism, and other central nervous system disorders.
Overall, Titan Pharmaceuticals utilizes innovative drug delivery technologies to develop long-term, sustainable treatment options for patients suffering from addiction and central nervous system disorders. Their focus on implantable devices aims to improve patient compliance and the overall efficacy of treatments for chronic conditions.